img

Global Longevity and Anti-Aging Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Longevity and Anti-Aging Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
Longevity and Anti-Aging Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Longevity and Anti-Aging Drugs market is projected to reach US$ 30400 million in 2029, increasing from US$ 13620 million in 2022, with the CAGR of 11.9% during the period of 2024 to 2029. Demand from Adult Male (Under 60 Years Old) and Adult Female (Under 60 Years Old) are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Longevity and Anti-Aging Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Vitality Pro
MoleQlar
Hansen Supplements
Supplement Place
Maxx Herb
Youth & Earth
Rejuvant LifeTabs
Renue By Science
Double Wood Supplements
Quicksilver Scientific
California Gold Nutrition
ProHealth Longevity
Peak Performance
Do Not Age
Nutriop
AFEGA Anti-Aging-Shop
Xi'an Angel Biotechnology Co., Ltd.
Longevity Box
Age Science
Nutravita
Aeternum
Toniiq
ProNutrition
Genex Formulas
Physicians Longevity
AlphaFit
Lovita Foods
Jarrow Formulas
Body Union
Segment by Type
Calcium AKG Supplement
Nicotinamide Mononucleotide Supplement
Others

Segment by Application


Adult Male (Under 60 Years Old)
Adult Female (Under 60 Years Old)
Elderly (Above 60 Years Old)

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Longevity and Anti-Aging Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Longevity and Anti-Aging Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Longevity and Anti-Aging Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Longevity and Anti-Aging Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Longevity and Anti-Aging Drugs introduction, etc. Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Longevity and Anti-Aging Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Longevity and Anti-Aging Drugs Market Overview
1.1 Longevity and Anti-Aging Drugs Product Overview
1.2 Longevity and Anti-Aging Drugs Market Segment by Type
1.2.1 Calcium AKG Supplement
1.2.2 Nicotinamide Mononucleotide Supplement
1.2.3 Others
1.3 Global Longevity and Anti-Aging Drugs Market Size by Type
1.3.1 Global Longevity and Anti-Aging Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Longevity and Anti-Aging Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Longevity and Anti-Aging Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Longevity and Anti-Aging Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Longevity and Anti-Aging Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Longevity and Anti-Aging Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Longevity and Anti-Aging Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Longevity and Anti-Aging Drugs Sales Breakdown by Type (2018-2024)
2 Global Longevity and Anti-Aging Drugs Market Competition by Company
2.1 Global Top Players by Longevity and Anti-Aging Drugs Sales (2018-2024)
2.2 Global Top Players by Longevity and Anti-Aging Drugs Revenue (2018-2024)
2.3 Global Top Players by Longevity and Anti-Aging Drugs Price (2018-2024)
2.4 Global Top Manufacturers Longevity and Anti-Aging Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Longevity and Anti-Aging Drugs Market Competitive Situation and Trends
2.5.1 Longevity and Anti-Aging Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Longevity and Anti-Aging Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Longevity and Anti-Aging Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Longevity and Anti-Aging Drugs Market
2.8 Key Manufacturers Longevity and Anti-Aging Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Longevity and Anti-Aging Drugs Status and Outlook by Region
3.1 Global Longevity and Anti-Aging Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Longevity and Anti-Aging Drugs Historic Market Size by Region
3.2.1 Global Longevity and Anti-Aging Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Longevity and Anti-Aging Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Longevity and Anti-Aging Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Longevity and Anti-Aging Drugs Forecasted Market Size by Region
3.3.1 Global Longevity and Anti-Aging Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Longevity and Anti-Aging Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Longevity and Anti-Aging Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Longevity and Anti-Aging Drugs by Application
4.1 Longevity and Anti-Aging Drugs Market Segment by Application
4.1.1 Adult Male (Under 60 Years Old)
4.1.2 Adult Female (Under 60 Years Old)
4.1.3 Elderly (Above 60 Years Old)
4.2 Global Longevity and Anti-Aging Drugs Market Size by Application
4.2.1 Global Longevity and Anti-Aging Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Longevity and Anti-Aging Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Longevity and Anti-Aging Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Longevity and Anti-Aging Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Longevity and Anti-Aging Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Longevity and Anti-Aging Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Longevity and Anti-Aging Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Longevity and Anti-Aging Drugs Sales Breakdown by Application (2018-2024)
5 North America Longevity and Anti-Aging Drugs by Country
5.1 North America Longevity and Anti-Aging Drugs Historic Market Size by Country
5.1.1 North America Longevity and Anti-Aging Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Longevity and Anti-Aging Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Longevity and Anti-Aging Drugs Sales in Value by Country (2018-2024)
5.2 North America Longevity and Anti-Aging Drugs Forecasted Market Size by Country
5.2.1 North America Longevity and Anti-Aging Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Longevity and Anti-Aging Drugs Sales in Value by Country (2024-2029)
6 Europe Longevity and Anti-Aging Drugs by Country
6.1 Europe Longevity and Anti-Aging Drugs Historic Market Size by Country
6.1.1 Europe Longevity and Anti-Aging Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Longevity and Anti-Aging Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Longevity and Anti-Aging Drugs Sales in Value by Country (2018-2024)
6.2 Europe Longevity and Anti-Aging Drugs Forecasted Market Size by Country
6.2.1 Europe Longevity and Anti-Aging Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Longevity and Anti-Aging Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Longevity and Anti-Aging Drugs by Region
7.1 Asia-Pacific Longevity and Anti-Aging Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Longevity and Anti-Aging Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Longevity and Anti-Aging Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Longevity and Anti-Aging Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Longevity and Anti-Aging Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Longevity and Anti-Aging Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Longevity and Anti-Aging Drugs Sales in Value by Region (2024-2029)
8 Latin America Longevity and Anti-Aging Drugs by Country
8.1 Latin America Longevity and Anti-Aging Drugs Historic Market Size by Country
8.1.1 Latin America Longevity and Anti-Aging Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Longevity and Anti-Aging Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Longevity and Anti-Aging Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Longevity and Anti-Aging Drugs Forecasted Market Size by Country
8.2.1 Latin America Longevity and Anti-Aging Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Longevity and Anti-Aging Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Longevity and Anti-Aging Drugs by Country
9.1 Middle East and Africa Longevity and Anti-Aging Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Longevity and Anti-Aging Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Longevity and Anti-Aging Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Longevity and Anti-Aging Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Longevity and Anti-Aging Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Longevity and Anti-Aging Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Longevity and Anti-Aging Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Vitality Pro
10.1.1 Vitality Pro Company Information
10.1.2 Vitality Pro Introduction and Business Overview
10.1.3 Vitality Pro Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Vitality Pro Longevity and Anti-Aging Drugs Products Offered
10.1.5 Vitality Pro Recent Development
10.2 MoleQlar
10.2.1 MoleQlar Company Information
10.2.2 MoleQlar Introduction and Business Overview
10.2.3 MoleQlar Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 MoleQlar Longevity and Anti-Aging Drugs Products Offered
10.2.5 MoleQlar Recent Development
10.3 Hansen Supplements
10.3.1 Hansen Supplements Company Information
10.3.2 Hansen Supplements Introduction and Business Overview
10.3.3 Hansen Supplements Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Hansen Supplements Longevity and Anti-Aging Drugs Products Offered
10.3.5 Hansen Supplements Recent Development
10.4 Supplement Place
10.4.1 Supplement Place Company Information
10.4.2 Supplement Place Introduction and Business Overview
10.4.3 Supplement Place Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Supplement Place Longevity and Anti-Aging Drugs Products Offered
10.4.5 Supplement Place Recent Development
10.5 Maxx Herb
10.5.1 Maxx Herb Company Information
10.5.2 Maxx Herb Introduction and Business Overview
10.5.3 Maxx Herb Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Maxx Herb Longevity and Anti-Aging Drugs Products Offered
10.5.5 Maxx Herb Recent Development
10.6 Youth & Earth
10.6.1 Youth & Earth Company Information
10.6.2 Youth & Earth Introduction and Business Overview
10.6.3 Youth & Earth Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Youth & Earth Longevity and Anti-Aging Drugs Products Offered
10.6.5 Youth & Earth Recent Development
10.7 Rejuvant LifeTabs
10.7.1 Rejuvant LifeTabs Company Information
10.7.2 Rejuvant LifeTabs Introduction and Business Overview
10.7.3 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Products Offered
10.7.5 Rejuvant LifeTabs Recent Development
10.8 Renue By Science
10.8.1 Renue By Science Company Information
10.8.2 Renue By Science Introduction and Business Overview
10.8.3 Renue By Science Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Renue By Science Longevity and Anti-Aging Drugs Products Offered
10.8.5 Renue By Science Recent Development
10.9 Double Wood Supplements
10.9.1 Double Wood Supplements Company Information
10.9.2 Double Wood Supplements Introduction and Business Overview
10.9.3 Double Wood Supplements Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Double Wood Supplements Longevity and Anti-Aging Drugs Products Offered
10.9.5 Double Wood Supplements Recent Development
10.10 Quicksilver Scientific
10.10.1 Quicksilver Scientific Company Information
10.10.2 Quicksilver Scientific Introduction and Business Overview
10.10.3 Quicksilver Scientific Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Quicksilver Scientific Longevity and Anti-Aging Drugs Products Offered
10.10.5 Quicksilver Scientific Recent Development
10.11 California Gold Nutrition
10.11.1 California Gold Nutrition Company Information
10.11.2 California Gold Nutrition Introduction and Business Overview
10.11.3 California Gold Nutrition Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 California Gold Nutrition Longevity and Anti-Aging Drugs Products Offered
10.11.5 California Gold Nutrition Recent Development
10.12 ProHealth Longevity
10.12.1 ProHealth Longevity Company Information
10.12.2 ProHealth Longevity Introduction and Business Overview
10.12.3 ProHealth Longevity Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 ProHealth Longevity Longevity and Anti-Aging Drugs Products Offered
10.12.5 ProHealth Longevity Recent Development
10.13 Peak Performance
10.13.1 Peak Performance Company Information
10.13.2 Peak Performance Introduction and Business Overview
10.13.3 Peak Performance Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Peak Performance Longevity and Anti-Aging Drugs Products Offered
10.13.5 Peak Performance Recent Development
10.14 Do Not Age
10.14.1 Do Not Age Company Information
10.14.2 Do Not Age Introduction and Business Overview
10.14.3 Do Not Age Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Do Not Age Longevity and Anti-Aging Drugs Products Offered
10.14.5 Do Not Age Recent Development
10.15 Nutriop
10.15.1 Nutriop Company Information
10.15.2 Nutriop Introduction and Business Overview
10.15.3 Nutriop Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Nutriop Longevity and Anti-Aging Drugs Products Offered
10.15.5 Nutriop Recent Development
10.16 AFEGA Anti-Aging-Shop
10.16.1 AFEGA Anti-Aging-Shop Company Information
10.16.2 AFEGA Anti-Aging-Shop Introduction and Business Overview
10.16.3 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Products Offered
10.16.5 AFEGA Anti-Aging-Shop Recent Development
10.17 Xi'an Angel Biotechnology Co., Ltd.
10.17.1 Xi'an Angel Biotechnology Co., Ltd. Company Information
10.17.2 Xi'an Angel Biotechnology Co., Ltd. Introduction and Business Overview
10.17.3 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Products Offered
10.17.5 Xi'an Angel Biotechnology Co., Ltd. Recent Development
10.18 Longevity Box
10.18.1 Longevity Box Company Information
10.18.2 Longevity Box Introduction and Business Overview
10.18.3 Longevity Box Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Longevity Box Longevity and Anti-Aging Drugs Products Offered
10.18.5 Longevity Box Recent Development
10.19 Age Science
10.19.1 Age Science Company Information
10.19.2 Age Science Introduction and Business Overview
10.19.3 Age Science Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Age Science Longevity and Anti-Aging Drugs Products Offered
10.19.5 Age Science Recent Development
10.20 Nutravita
10.20.1 Nutravita Company Information
10.20.2 Nutravita Introduction and Business Overview
10.20.3 Nutravita Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Nutravita Longevity and Anti-Aging Drugs Products Offered
10.20.5 Nutravita Recent Development
10.21 Aeternum
10.21.1 Aeternum Company Information
10.21.2 Aeternum Introduction and Business Overview
10.21.3 Aeternum Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Aeternum Longevity and Anti-Aging Drugs Products Offered
10.21.5 Aeternum Recent Development
10.22 Toniiq
10.22.1 Toniiq Company Information
10.22.2 Toniiq Introduction and Business Overview
10.22.3 Toniiq Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Toniiq Longevity and Anti-Aging Drugs Products Offered
10.22.5 Toniiq Recent Development
10.23 ProNutrition
10.23.1 ProNutrition Company Information
10.23.2 ProNutrition Introduction and Business Overview
10.23.3 ProNutrition Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.23.4 ProNutrition Longevity and Anti-Aging Drugs Products Offered
10.23.5 ProNutrition Recent Development
10.24 Genex Formulas
10.24.1 Genex Formulas Company Information
10.24.2 Genex Formulas Introduction and Business Overview
10.24.3 Genex Formulas Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Genex Formulas Longevity and Anti-Aging Drugs Products Offered
10.24.5 Genex Formulas Recent Development
10.25 Physicians Longevity
10.25.1 Physicians Longevity Company Information
10.25.2 Physicians Longevity Introduction and Business Overview
10.25.3 Physicians Longevity Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.25.4 Physicians Longevity Longevity and Anti-Aging Drugs Products Offered
10.25.5 Physicians Longevity Recent Development
10.26 AlphaFit
10.26.1 AlphaFit Company Information
10.26.2 AlphaFit Introduction and Business Overview
10.26.3 AlphaFit Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.26.4 AlphaFit Longevity and Anti-Aging Drugs Products Offered
10.26.5 AlphaFit Recent Development
10.27 Lovita Foods
10.27.1 Lovita Foods Company Information
10.27.2 Lovita Foods Introduction and Business Overview
10.27.3 Lovita Foods Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.27.4 Lovita Foods Longevity and Anti-Aging Drugs Products Offered
10.27.5 Lovita Foods Recent Development
10.28 Jarrow Formulas
10.28.1 Jarrow Formulas Company Information
10.28.2 Jarrow Formulas Introduction and Business Overview
10.28.3 Jarrow Formulas Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.28.4 Jarrow Formulas Longevity and Anti-Aging Drugs Products Offered
10.28.5 Jarrow Formulas Recent Development
10.29 Body Union
10.29.1 Body Union Company Information
10.29.2 Body Union Introduction and Business Overview
10.29.3 Body Union Longevity and Anti-Aging Drugs Sales, Revenue and Gross Margin (2018-2024)
10.29.4 Body Union Longevity and Anti-Aging Drugs Products Offered
10.29.5 Body Union Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Longevity and Anti-Aging Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Longevity and Anti-Aging Drugs Industrial Chain Analysis
11.4 Longevity and Anti-Aging Drugs Market Dynamics
11.4.1 Longevity and Anti-Aging Drugs Industry Trends
11.4.2 Longevity and Anti-Aging Drugs Market Drivers
11.4.3 Longevity and Anti-Aging Drugs Market Challenges
11.4.4 Longevity and Anti-Aging Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Longevity and Anti-Aging Drugs Distributors
12.3 Longevity and Anti-Aging Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Calcium AKG Supplement
Table 2. Major Company of Nicotinamide Mononucleotide Supplement
Table 3. Major Company of Others
Table 4. Global Longevity and Anti-Aging Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Longevity and Anti-Aging Drugs Sales by Type (2018-2024) & (Tons)
Table 6. Global Longevity and Anti-Aging Drugs Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Longevity and Anti-Aging Drugs Sales by Type (2018-2024) & (US& Million)
Table 8. Global Longevity and Anti-Aging Drugs Market Share in Value by Type (2018-2024)
Table 9. Global Longevity and Anti-Aging Drugs Price by Type (2018-2024) & (US$/Ton)
Table 10. Global Longevity and Anti-Aging Drugs Sales by Type (2024-2029) & (Tons)
Table 11. Global Longevity and Anti-Aging Drugs Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Longevity and Anti-Aging Drugs Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Longevity and Anti-Aging Drugs Sales Market Share in Value by Type (2024-2029)
Table 14. Global Longevity and Anti-Aging Drugs Price by Type (2024-2029) & (US$/Ton)
Table 15. North America Longevity and Anti-Aging Drugs Sales by Type (2018-2024) & (Tons)
Table 16. North America Longevity and Anti-Aging Drugs Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Longevity and Anti-Aging Drugs Sales (Tons) by Type (2018-2024)
Table 18. Europe Longevity and Anti-Aging Drugs Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Longevity and Anti-Aging Drugs Sales (Tons) by Type (2018-2024)
Table 20. Asia-Pacific Longevity and Anti-Aging Drugs Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Longevity and Anti-Aging Drugs Sales (Tons) by Type (2018-2024)
Table 22. Latin America Longevity and Anti-Aging Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Longevity and Anti-Aging Drugs Sales (Tons) by Type (2018-2024)
Table 24. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Longevity and Anti-Aging Drugs Sales by Company (2018-2024) & (Tons)
Table 26. Global Longevity and Anti-Aging Drugs Sales Share by Company (2018-2024)
Table 27. Global Longevity and Anti-Aging Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Longevity and Anti-Aging Drugs Revenue Share by Company (2018-2024)
Table 29. Global Market Longevity and Anti-Aging Drugs Price by Company (2018-2024) & (US$/Ton)
Table 30. Global Longevity and Anti-Aging Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Longevity and Anti-Aging Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Longevity and Anti-Aging Drugs as of 2022)
Table 33. Date of Key Manufacturers Enter into Longevity and Anti-Aging Drugs Market
Table 34. Key Manufacturers Longevity and Anti-Aging Drugs Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Longevity and Anti-Aging Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Longevity and Anti-Aging Drugs Sales by Region (2018-2024) & (Tons)
Table 38. Global Longevity and Anti-Aging Drugs Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Longevity and Anti-Aging Drugs Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Longevity and Anti-Aging Drugs Sales Market Share in Value by Region (2018-2024)
Table 41. Global Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 42. Global Longevity and Anti-Aging Drugs Sales by Region (2024-2029) & (Tons)
Table 43. Global Longevity and Anti-Aging Drugs Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Longevity and Anti-Aging Drugs Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Longevity and Anti-Aging Drugs Sales Market Share in Value by Region (2024-2029)
Table 46. Global Longevity and Anti-Aging Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2029)
Table 47. Global Longevity and Anti-Aging Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Longevity and Anti-Aging Drugs Sales by Application (2018-2024) & (Tons)
Table 49. Global Longevity and Anti-Aging Drugs Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Longevity and Anti-Aging Drugs Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Longevity and Anti-Aging Drugs Sales Market Share in Value by Application (2018-2024)
Table 52. Global Longevity and Anti-Aging Drugs Price by Application (2018-2024) & (US$/Ton)
Table 53. Global Longevity and Anti-Aging Drugs Sales by Application (2024-2029) & (Tons)
Table 54. Global Longevity and Anti-Aging Drugs Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Longevity and Anti-Aging Drugs Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Longevity and Anti-Aging Drugs Sales Market Share in Value by Application (2024-2029)
Table 57. Global Longevity and Anti-Aging Drugs Price by Application (2024-2029) & (US$/Ton)
Table 58. North America Longevity and Anti-Aging Drugs Sales by Application (2018-2024) (Tons)
Table 59. North America Longevity and Anti-Aging Drugs Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Longevity and Anti-Aging Drugs Sales by Application (2018-2024) (Tons)
Table 61. Europe Longevity and Anti-Aging Drugs Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Longevity and Anti-Aging Drugs Sales by Application (2018-2024) (Tons)
Table 63. Asia-Pacific Longevity and Anti-Aging Drugs Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Longevity and Anti-Aging Drugs Sales by Application (2018-2024) (Tons)
Table 65. Latin America Longevity and Anti-Aging Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Application (2018-2024) (Tons)
Table 67. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (Tons)
Table 69. North America Longevity and Anti-Aging Drugs Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Longevity and Anti-Aging Drugs Sales Market Share in Value by Country (2018-2024)
Table 72. North America Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (Tons)
Table 73. North America Longevity and Anti-Aging Drugs Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Longevity and Anti-Aging Drugs Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (Tons)
Table 77. Europe Longevity and Anti-Aging Drugs Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Longevity and Anti-Aging Drugs Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (Tons)
Table 81. Europe Longevity and Anti-Aging Drugs Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Longevity and Anti-Aging Drugs Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Longevity and Anti-Aging Drugs Sales by Region (2018-2024) & (Tons)
Table 85. Asia-Pacific Longevity and Anti-Aging Drugs Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Longevity and Anti-Aging Drugs Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Longevity and Anti-Aging Drugs Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Longevity and Anti-Aging Drugs Sales by Region (2024-2029) & (Tons)
Table 89. Asia-Pacific Longevity and Anti-Aging Drugs Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Longevity and Anti-Aging Drugs Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Longevity and Anti-Aging Drugs Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (Tons)
Table 93. Latin America Longevity and Anti-Aging Drugs Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Longevity and Anti-Aging Drugs Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (Tons)
Table 97. Latin America Longevity and Anti-Aging Drugs Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Longevity and Anti-Aging Drugs Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (Tons)
Table 101. Middle East and Africa Longevity and Anti-Aging Drugs Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Longevity and Anti-Aging Drugs Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (Tons)
Table 105. Middle East and Africa Longevity and Anti-Aging Drugs Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Longevity and Anti-Aging Drugs Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Longevity and Anti-Aging Drugs Sales Market Share in Value by Country (2024-2029)
Table 108. Vitality Pro Company Information
Table 109. Vitality Pro Introduction and Business Overview
Table 110. Vitality Pro Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 111. Vitality Pro Longevity and Anti-Aging Drugs Product
Table 112. Vitality Pro Recent Development
Table 113. MoleQlar Company Information
Table 114. MoleQlar Introduction and Business Overview
Table 115. MoleQlar Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 116. MoleQlar Longevity and Anti-Aging Drugs Product
Table 117. MoleQlar Recent Development
Table 118. Hansen Supplements Company Information
Table 119. Hansen Supplements Introduction and Business Overview
Table 120. Hansen Supplements Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 121. Hansen Supplements Longevity and Anti-Aging Drugs Product
Table 122. Hansen Supplements Recent Development
Table 123. Supplement Place Company Information
Table 124. Supplement Place Introduction and Business Overview
Table 125. Supplement Place Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 126. Supplement Place Longevity and Anti-Aging Drugs Product
Table 127. Supplement Place Recent Development
Table 128. Maxx Herb Company Information
Table 129. Maxx Herb Introduction and Business Overview
Table 130. Maxx Herb Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 131. Maxx Herb Longevity and Anti-Aging Drugs Product
Table 132. Maxx Herb Recent Development
Table 133. Youth & Earth Company Information
Table 134. Youth & Earth Introduction and Business Overview
Table 135. Youth & Earth Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 136. Youth & Earth Longevity and Anti-Aging Drugs Product
Table 137. Youth & Earth Recent Development
Table 138. Rejuvant LifeTabs Company Information
Table 139. Rejuvant LifeTabs Introduction and Business Overview
Table 140. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 141. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product
Table 142. Rejuvant LifeTabs Recent Development
Table 143. Renue By Science Company Information
Table 144. Renue By Science Introduction and Business Overview
Table 145. Renue By Science Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 146. Renue By Science Longevity and Anti-Aging Drugs Product
Table 147. Renue By Science Recent Development
Table 148. Double Wood Supplements Company Information
Table 149. Double Wood Supplements Introduction and Business Overview
Table 150. Double Wood Supplements Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 151. Double Wood Supplements Longevity and Anti-Aging Drugs Product
Table 152. Double Wood Supplements Recent Development
Table 153. Quicksilver Scientific Company Information
Table 154. Quicksilver Scientific Introduction and Business Overview
Table 155. Quicksilver Scientific Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 156. Quicksilver Scientific Longevity and Anti-Aging Drugs Product
Table 157. Quicksilver Scientific Recent Development
Table 158. California Gold Nutrition Company Information
Table 159. California Gold Nutrition Introduction and Business Overview
Table 160. California Gold Nutrition Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 161. California Gold Nutrition Longevity and Anti-Aging Drugs Product
Table 162. California Gold Nutrition Recent Development
Table 163. ProHealth Longevity Company Information
Table 164. ProHealth Longevity Introduction and Business Overview
Table 165. ProHealth Longevity Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 166. ProHealth Longevity Longevity and Anti-Aging Drugs Product
Table 167. ProHealth Longevity Recent Development
Table 168. Peak Performance Company Information
Table 169. Peak Performance Introduction and Business Overview
Table 170. Peak Performance Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 171. Peak Performance Longevity and Anti-Aging Drugs Product
Table 172. Peak Performance Recent Development
Table 173. Do Not Age Company Information
Table 174. Do Not Age Introduction and Business Overview
Table 175. Do Not Age Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 176. Do Not Age Longevity and Anti-Aging Drugs Product
Table 177. Do Not Age Recent Development
Table 178. Nutriop Company Information
Table 179. Nutriop Introduction and Business Overview
Table 180. Nutriop Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 181. Nutriop Longevity and Anti-Aging Drugs Product
Table 182. Nutriop Recent Development
Table 183. AFEGA Anti-Aging-Shop Company Information
Table 184. AFEGA Anti-Aging-Shop Introduction and Business Overview
Table 185. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 186. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product
Table 187. AFEGA Anti-Aging-Shop Recent Development
Table 188. Xi'an Angel Biotechnology Co., Ltd. Company Information
Table 189. Xi'an Angel Biotechnology Co., Ltd. Introduction and Business Overview
Table 190. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 191. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product
Table 192. Xi'an Angel Biotechnology Co., Ltd. Recent Development
Table 193. Longevity Box Company Information
Table 194. Longevity Box Introduction and Business Overview
Table 195. Longevity Box Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 196. Longevity Box Longevity and Anti-Aging Drugs Product
Table 197. Longevity Box Recent Development
Table 198. Age Science Company Information
Table 199. Age Science Introduction and Business Overview
Table 200. Age Science Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 201. Age Science Longevity and Anti-Aging Drugs Product
Table 202. Age Science Recent Development
Table 203. Nutravita Company Information
Table 204. Nutravita Introduction and Business Overview
Table 205. Nutravita Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 206. Nutravita Longevity and Anti-Aging Drugs Product
Table 207. Nutravita Recent Development
Table 208. Aeternum Company Information
Table 209. Aeternum Introduction and Business Overview
Table 210. Aeternum Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 211. Aeternum Longevity and Anti-Aging Drugs Product
Table 212. Aeternum Recent Development
Table 213. Toniiq Company Information
Table 214. Toniiq Introduction and Business Overview
Table 215. Toniiq Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 216. Toniiq Longevity and Anti-Aging Drugs Product
Table 217. Toniiq Recent Development
Table 218. ProNutrition Company Information
Table 219. ProNutrition Introduction and Business Overview
Table 220. ProNutrition Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 221. ProNutrition Longevity and Anti-Aging Drugs Product
Table 222. ProNutrition Recent Development
Table 223. Genex Formulas Company Information
Table 224. Genex Formulas Introduction and Business Overview
Table 225. Genex Formulas Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 226. Genex Formulas Longevity and Anti-Aging Drugs Product
Table 227. Genex Formulas Recent Development
Table 228. Physicians Longevity Introduction and Business Overview
Table 229. Physicians Longevity Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 230. Physicians Longevity Longevity and Anti-Aging Drugs Product
Table 231. Physicians Longevity Recent Development
Table 232. Physicians Longevity Company Information
Table 233. AlphaFit Company Information
Table 234. AlphaFit Introduction and Business Overview
Table 235. AlphaFit Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 236. AlphaFit Longevity and Anti-Aging Drugs Product
Table 237. AlphaFit Recent Development
Table 238. Lovita Foods Company Information
Table 239. Lovita Foods Introduction and Business Overview
Table 240. Lovita Foods Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 241. Lovita Foods Longevity and Anti-Aging Drugs Product
Table 242. Lovita Foods Recent Development
Table 243. Jarrow Formulas Company Information
Table 244. Jarrow Formulas Introduction and Business Overview
Table 245. Jarrow Formulas Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 246. Jarrow Formulas Longevity and Anti-Aging Drugs Product
Table 247. Jarrow Formulas Recent Development
Table 248. Body Union Company Information
Table 249. Body Union Introduction and Business Overview
Table 250. Body Union Longevity and Anti-Aging Drugs Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 251. Body Union Longevity and Anti-Aging Drugs Product
Table 252. Body Union Recent Development
Table 253. Key Raw Materials Lists
Table 254. Raw Materials Key Suppliers Lists
Table 255. Longevity and Anti-Aging Drugs Market Trends
Table 256. Longevity and Anti-Aging Drugs Market Drivers
Table 257. Longevity and Anti-Aging Drugs Market Challenges
Table 258. Longevity and Anti-Aging Drugs Market Restraints
Table 259. Longevity and Anti-Aging Drugs Distributors List
Table 260. Longevity and Anti-Aging Drugs Downstream Customers
Table 261. Research Programs/Design for This Report
Table 262. Key Data Information from Secondary Sources
Table 263. Key Data Information from Primary Sources
List of Figures
Figure 1. Longevity and Anti-Aging Drugs Product Picture
Figure 2. Global Longevity and Anti-Aging Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Longevity and Anti-Aging Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Longevity and Anti-Aging Drugs Sales Status and Outlook (2018-2029) & (Tons)
Figure 5. Product Picture of Calcium AKG Supplement
Figure 6. Global Calcium AKG Supplement Sales YoY Growth (2018-2029) & (Tons)
Figure 7. Product Picture of Nicotinamide Mononucleotide Supplement
Figure 8. Global Nicotinamide Mononucleotide Supplement Sales YoY Growth (2018-2029) & (Tons)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2029) & (Tons)
Figure 11. Global Longevity and Anti-Aging Drugs Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Longevity and Anti-Aging Drugs Sales Market Share by Type in 2022 & 2029
Figure 13. North America Longevity and Anti-Aging Drugs Sales Market Share in Volume by Type in 2022
Figure 14. North America Longevity and Anti-Aging Drugs Sales Market Share in Value by Type in 2022
Figure 15. Europe Longevity and Anti-Aging Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Europe Longevity and Anti-Aging Drugs Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Longevity and Anti-Aging Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Longevity and Anti-Aging Drugs Sales Market Share in Value by Type in 2022
Figure 19. Latin America Longevity and Anti-Aging Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Longevity and Anti-Aging Drugs Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Longevity and Anti-Aging Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Longevity and Anti-Aging Drugs Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Longevity and Anti-Aging Drugs Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Longevity and Anti-Aging Drugs Revenue in 2022
Figure 25. Longevity and Anti-Aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Adult Male (Under 60 Years Old)
Figure 27. Global Adult Male (Under 60 Years Old) Sales YoY Growth (2018-2029) & (Tons)
Figure 28. Product Picture of Adult Female (Under 60 Years Old)
Figure 29. Global Adult Female (Under 60 Years Old) Sales YoY Growth (2018-2029) & (Tons)
Figure 30. Product Picture of Elderly (Above 60 Years Old)
Figure 31. Global Elderly (Above 60 Years Old) Sales YoY Growth (2018-2029) & (Tons)
Figure 32. Global Longevity and Anti-Aging Drugs Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Longevity and Anti-Aging Drugs Sales Market Share by Application in 2022 & 2029
Figure 34. North America Longevity and Anti-Aging Drugs Sales Market Share in Volume by Application in 2022
Figure 35. North America Longevity and Anti-Aging Drugs Sales Market Share in Value by Application in 2022
Figure 36. Europe Longevity and Anti-Aging Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Europe Longevity and Anti-Aging Drugs Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Longevity and Anti-Aging Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Longevity and Anti-Aging Drugs Sales Market Share in Value by Application in 2022
Figure 40. Latin America Longevity and Anti-Aging Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Longevity and Anti-Aging Drugs Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Longevity and Anti-Aging Drugs Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Longevity and Anti-Aging Drugs Manufacturing Cost Structure
Figure 45. Longevity and Anti-Aging Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed